Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2009
10/13/2009CA2384037C Pyrazolo[4,3-d]pyrimidines
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/08/2009WO2009124259A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123986A1 Apoptosis signal-regulating kinase 1 inhibitors
10/08/2009WO2009123968A1 Lyotropic liquid crystal systems based on bisacenaphthopyrazinoquinoxaline derivatives and methods of making
10/08/2009WO2009123967A1 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine h4 receptor modulators for the treatment of asthma
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123537A1 GABAa RECEPTOR MODULATORS
10/08/2009WO2009123154A1 Ultraviolet absorbing material
10/08/2009WO2009123056A1 Compound capable of absorbing infrared ray, and microparticles comprising the compound
10/08/2009WO2009122664A1 Photobase generator
10/08/2009WO2009121919A1 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/08/2009WO2009121791A1 CONVERSION OF TRYPTOPHAN INTO ß-CARBOLINE DERIVATIVES
10/08/2009WO2009095792A3 Substituted heteroarylamide diazepinopyrimidone derivatives
10/08/2009WO2009093210A3 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
10/08/2009WO2009093209A3 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253716 Amino-imidazolones for the inhibition of beta-secretase
10/08/2009US20090253713 Small Molecule Compositions for Sexual Dysfunction
10/08/2009US20090253704 PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253677 HIV Integrase Inhibitors
10/08/2009US20090252678 Cox-2-targeted imaging agents
10/08/2009CA2720464A1 Gabaa receptor modulators
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719526A1 Conversion of tryptophan into .beta.-carboline derivatives
10/08/2009CA2719362A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009CA2716410A1 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/07/2009EP2107059A1 Conversion of tryptophan into ß-carboline derivatives
10/07/2009EP2106401A2 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
10/07/2009EP1537113B1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/07/2009CN101553491A Quinoxaline derivative
10/07/2009CN101553490A Bicyclic triazoles as protein kinase modulators
10/07/2009CN101553489A 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
10/07/2009CN101550140A Method and apparatus for synthesis of tetaraary porphyrin
10/07/2009CN101550139A Dipeptidase-IV inhibitor containing v-triazolo [b] pyrazine
10/06/2009US7598395 Heterocyclocarboxamide derivatives
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598380 Method of preparation of azaindole derivatives
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598259 mGluR1 antagonists as therapeutic agents
10/06/2009US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
10/06/2009US7598256 Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009US7598252 Compounds specific to adenosine A, receptors and uses thereof
10/06/2009US7598247 Immunomodulating heterocyclic compounds
10/06/2009US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2616580C Macrocyclic inhibitors of hepatitis c virus
10/06/2009CA2368095C Process for preparing inhibitors of nucleoside metabolism
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009121063A2 Chemokine receptor modulators
10/01/2009WO2009121036A2 Substituted aryl pyrimidinone derivatives
10/01/2009WO2009120954A2 Nicotine immunoconjugates
10/01/2009WO2009120746A2 Crystalline forms of sitagliptin phosphate
10/01/2009WO2009120745A1 Compounds for the treatment of hepatitis c
10/01/2009WO2009120733A1 Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120660A2 Substituted pyridoxazines
10/01/2009WO2009120650A1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120094A2 Substituted pyrimidines and triazines and their use in cancer therapy
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119528A1 Heterocyclic compound
10/01/2009WO2009119412A1 Water-soluble azo compound or salt thereof, ink composition and colored body
10/01/2009WO2009119249A1 Organic electroluminescent device
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118749A1 Benzophenone-piperazine linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
10/01/2009WO2009118748A1 Isoxazoline linked pyrrolo[2,1-c[1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof
10/01/2009WO2009094428A3 N- and o-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating cns disorders therewith
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
10/01/2009WO2009030649A3 Method for producing teda derivatives
10/01/2009US20090247751 Process for the preparation of zaleplon and an intermediate thereof
10/01/2009US20090247750 Process for preparing nucleoside analogs
10/01/2009US20090247748 Process for producing sulfonyl chloride compound
10/01/2009US20090247744 Hydroformylation process for pharmaceutical intermediate
10/01/2009US20090247564 Crystalline Form of Vinflunine Ditartrate
10/01/2009US20090247559 Benzofuropyrimidinones
10/01/2009US20090247556 Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity
10/01/2009US20090247548 Pyrrolopyrimidine derivatives for treating proliferative diseases
10/01/2009US20090247539 Novel Pharmaceuticals
10/01/2009US20090247538 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
10/01/2009US20090247532 Crystalline polymorph of sitagliptin phosphate and its preparation
10/01/2009US20090247531 CRYSTALLINE FORMS OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
10/01/2009US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2718727A1 Heterocyclic compound
10/01/2009CA2718618A1 Chemokine receptor modulators
10/01/2009CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
09/2009
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009EP2104676A2 Methods for preparing arene-bis(dicarboximide)-based semiconducting materials and related intermediates for preparing same
09/30/2009EP1940844B1 Compounds and compositions as protein kinase inhibitors
09/30/2009EP1395117B2 Use of triazolopyrimidine derivatives as microbicides in the protection of materials
09/30/2009CN101547925A Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments
09/30/2009CN101547924A Compounds for inhibiting mitotic progression
09/30/2009CN101544650A Iodo-copper phthalocyanine nano-bar material and synthesizing method thereof
09/30/2009CN101544649A Synthetic porous crystalline MCM-68, its synthesis and use
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 573